Swedish Orphan Biovitrum and Shire discontinue distribution agreements
This article was originally published in Scrip
Executive Summary
Swedish Orphan Biovitrum and Shire are discontinuing their marketing, distribution and medical support agreement covering Xagrid (anagrelide), Fosrenol (lanthanum carbonate), and Equasym (methylphenidate) in the Nordic countries when the various distribution contracts expire during 2011.